2025-04-24 - Analysis Report
## Procter & Gamble Co (PG) Stock Review

**0. Executive Summary:**

Procter & Gamble Co (PG) is a multinational consumer goods company that manufactures and markets a wide variety of products.  This report analyzes PG's recent performance, comparing it to the S&P 500 (VOO), and examining key financial metrics.

**1. Performance Comparison with S&P 500:**

Procter & Gamble's cumulative return (82.37%) outperformed the S&P 500's cumulative return (78.93%) by 3.44 percentage points. While this represents a positive outperformance, the relative outperformance (47.9% based on historical maximum and minimum deviations) indicates that this is not exceptionally high compared to its historical performance.  The provided alpha values show that the company has consistently outperformed the market, with a significant alpha of 0.3 in several periods. Beta values are relatively stable around 0.3.  This suggests a moderate sensitivity to market movements but with consistent outperformance. The company's market capitalization has grown steadily over the years.

**Alpha, Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 27.0% | 7.9% | -0.0 | 0.3 | 176.7 |
| 2016-2018  | 8.0% | 56.9% | 0.1 | 0.3 | 183.0 |
| 2017-2019  | 37.0% | 56.9% | 0.3 | 0.3 | 255.7 |
| 2018-2020  | 52.0% | 59.2% | 0.3 | 0.3 | 291.9 |
| 2019-2021  | 71.0% | 59.2% | 0.3 | 0.3 | 351.8 |
| 2020-2022  | 32.0% | 74.7% | 0.3 | 0.3 | 334.0 |
| 2021-2023  | 34.0% | 74.7% | 0.3 | 0.3 | 331.2 |
| 2022-2024  | 9.0% | 74.7% | 0.3 | 0.3 | 388.3 |
| 2023-2025  | 3.0% | 70.5% | 0.2 | 0.3 | 388.6 |


**2. Recent Price Movement:**

* **Closing Price:** $165.73
* **Previous Close:** $167.88
* **Change:** -$1.28 (a decrease of approximately 0.8%)
* **5-Day Moving Average:** $166.86
* **20-Day Moving Average:** $165.89
* **60-Day Moving Average:** $167.53

The price is currently slightly below its 5-day and 60-day moving averages, but above its 20-day moving average, suggesting a slight downward trend in the short term, although the price is nearing the 20 day moving average.


**3. Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4174 (Medium Risk)
* **RSI:** 46.80 (Approaching oversold territory, but not yet decisively so)
* **PPO:** 0.23 (Positive, suggesting upward momentum)
* **20-Day Relative Divergence Change:** -2.2 (Short-term downward trend)
* **Expected Return (2+ years):** 16.3% (This is significantly above the market which indicates a strong expectation of future outperformance; however, this is a projection and not guaranteed.)

The recent price drop (-$1.28) reflects a small negative change but doesn't indicate a significant event like a sharp drop or rebound.


**4. Recent Earnings Analysis:**

| Date       | EPS  | Revenue       |
|------------|------|---------------|
| 2025-01-22 | 1.94 | $21.88B       |
| 2024-10-18 | 1.65 | $21.74B       |
| 2024-04-19 | 1.56 | $20.20B       |
| 2024-01-23 | 1.44 | $21.44B       |
| 2025-01-22 | 1.44 | $21.44B       |

There appears to be a duplicated entry for 2025-01-22.  Excluding the duplicate, revenue shows some fluctuation, but generally remains consistent around $21 Billion. EPS shows a clear increase in the most recent quarter.  Further analysis would be needed to understand the drivers behind these variations (e.g., seasonal effects, specific product performance).

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue  | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $21.88B | 52.39%       |
| 2024-09-30 | $21.74B | 52.06%       |
| 2024-06-30 | $20.53B | 49.60%       |
| 2024-03-31 | $20.20B | 51.20%       |
| 2023-12-31 | $21.44B | 52.69%       |

Revenue is relatively stable, with a slight dip in Q2 2024. Profit margins are consistently high and show minor fluctuations.

**Capital and Profitability:**

| Quarter | Equity   | ROE    |
|---------|----------|--------|
| 2024-12-31 | $51.17B | 9.05%  |
| 2024-09-30 | $51.84B | 7.64%  |
| 2024-06-30 | $50.29B | 6.24%  |
| 2024-03-31 | $50.06B | 7.50%  |
| 2023-12-31 | $48.53B | 7.15%  |

Equity shows some fluctuation but remains high. ROE also shows some variability, but overall remains positive.  Further investigation is needed to understand the factors influencing these changes.


**6. Overall Analysis:**

PG shows consistent outperformance against the S&P 500, backed by strong and relatively stable financial metrics. Although the recent price shows a slight downward trend, technical indicators suggest the stock is not in oversold territory. Earnings demonstrate growth and high profit margins, reinforcing the companyâ€™s financial strength.  The high projected return reflects optimism about the company's future prospects, but it's crucial to remember that this is just a prediction, not a guarantee.  Further research should focus on understanding the drivers behind recent revenue and ROE variations.  The projected high return over the next few years remains positive for long term investors.
